STAAR Surgical
STAA | NASDAQ
$20.88
+$0.56 (+2.76%)
Sep 22, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Jan 1, 2026 | FY 2024 Dec 26, 2024 | FY 2023 Dec 28, 2023 | FY 2022 Dec 29, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 239.44M | 313.9M | 322.42M | 284.39M | 230.47M | 163.46M |
Cost of Revenue | 57.02M | 74.32M | 69.76M | 61.01M | 51.84M | 45.1M |
Gross Profit | 182.42M | 239.58M | 252.65M | 223.38M | 178.64M | 118.36M |
Operating Income | -45.95M | -12.61M | 28.1M | 43.8M | 33.34M | 6.77M |
Interest Income | 4.59M | 5.91M | 6.99M | 2.45M | n/a | 238K |
Pretax Income | -82.26M | -9.05M | 33.7M | 45.55M | 31.3M | 8.27M |
Net Income | -80.45M | -20.21M | 21.35M | 39.67M | 27.51M | 5.91M |
Selling & General & Admin | 188.31M | 198.22M | 180.15M | 143.6M | 111.44M | 79.68M |
Research & Development | 40.06M | 53.97M | 44.4M | 35.98M | 33.86M | 31.92M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 228.37M | 252.19M | 224.55M | 179.58M | 145.3M | 111.59M |
Interest Expense | n/a | n/a | n/a | n/a | 38K | n/a |
Selling & Marketing Expenses | 102.53M | 108.32M | 107.83M | 88.86M | 67.29M | 45.76M |
Cost & Expenses | 285.39M | 326.51M | 294.32M | 240.59M | 197.13M | 156.69M |
Income Tax Expense | -1.82M | 11.16M | 12.35M | 5.89M | 3.79M | 2.35M |
Shares Outstanding (Basic) | 49.57M | 49.13M | 48.52M | 47.99M | 47.21M | 45.61M |
Shares Outstanding (Diluted) | 49.57M | 49.13M | 49.43M | 49.38M | 49.46M | 47.95M |
EPS (Basic) | -1.62 | -0.41 | 0.44 | 0.83 | 0.52 | 0.13 |
EPS (Diluted) | -1.62 | -0.41 | 0.43 | 0.80 | 0.50 | 0.12 |
EBITDA | -73.54M | -2.16M | 38.82M | 50.06M | 34.98M | 9.86M |
EBIT | -82.26M | -9.05M | 33.7M | 45.55M | 31.34M | 6.77M |
Depreciation & Amortization | 8.73M | 6.89M | 5.12M | 4.51M | 3.64M | 3.1M |
Add to Watchlist
Select watchlists to add or remove STAA